Tenax Therapeutics Inc.

NASDAQ: TENX · Real-Time Price · USD
5.90
-0.05 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
6.09
3.22%
After-hours: Aug 15, 2025, 05:30 PM EDT

Tenax Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2K 2K 2K 5.79K 5.79K 5.79K 5.79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1K 2K 2K 5.67K 6.67K 6.67K 7.57K 32.1K 59.61K 86.62K 113.33K 110.96K 108.71K 106.37K 108.98K 82.15K 55.88K 30.22K
Gross Profit
1K n/a n/a 120.00 -880 -880 -1.77K -32.1K -59.61K -86.62K -113.33K -110.96K -108.71K -106.37K -108.98K -82.15K -55.88K -30.22K
Operating Income
-50.2M -42.08M -34.65M -16.09M -18.59M -16.15M -13.79M -20.21M -19.41M -21.03M -16.78M -437.55K -7.16M -6.26M -32.73M -32.35M -30.77M -30.95M
Interest Income
3.58M 2.73M 1.8M 769.61K 255.62K 290.6K 290.6K 290.6K 139.86K 63.00 63.00 63.00 63.00 n/a n/a n/a n/a n/a
Pretax Income
-31.48M -24.21M -17.6M -14.56M -12.57M -10.1M -7.71M -7.03M -7.98M -9.73M -11.05M -11.71M -12.59M -11.45M -32.47M -32.09M -30.52M -30.94M
Net Income
-31.48M -24.21M -17.6M -14.56M -12.57M -10.1M -7.71M -7.03M -7.98M -9.73M -11.05M -11.71M -12.59M -11.45M -32.47M -32.09M -30.52M -30.94M
Selling & General & Admin
15.53M 11.21M 6.79M 5.73M 5.27M 4.96M 5.01M 4.78M 5.11M 5.41M 5.68M 6.55M 7.81M 7.75M 7.58M 7.23M 5.76M 5.36M
Research & Development
19.51M 15.72M 12.71M 9.81M 7.77M 5.64M 3.23M 2.66M 3.14M 4.47M 5.38M 5.16M 4.78M 3.95M 25.15M 25.12M 25.01M 25.59M
Other Expenses
24.4M 24.4M 24.4M 9.79M 5.55M 5.55M 5.55M -4.23M -5.83M -5.83M -11.27M -11.27M -5.44M -5.44M n/a n/a n/a n/a
Operating Expenses
59.44M 51.32M 43.89M 25.33M 18.59M 16.15M 13.79M 3.21M 2.41M 4.04M -219.61K 437.55K 7.16M 6.26M 32.73M 32.35M 30.77M 30.95M
Interest Expense
5.85K 15.04K 23K 25.62K 24.64K 24.58K 23.97K 25.88K 20.92K 13.28K 8.51K 4.44K 4.07K 2.92K 949.00 1.56K 2.17K 2.24K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
50.2M 42.08M 34.65M 6.3M 8.8M 6.37M 4M 3.21M 2.41M 4.04M -219.61K 437.55K 7.16M 6.26M 32.73M 32.35M 30.77M 30.95M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -4.07K -4.07K -4.07K -4.07K n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
39.57M 36.58M 15.27M 21.16M 1.96M 1.22M 248.45K 298.28K 276.45K 116.26K 1.47M 16.46K 15.75K 15.75K 20.58M 15.75K 10.76K 14.52M
Shares Outstanding (Diluted)
39.57M 36.58M 15.27M 21.16M 1.96M 1.22M 248.45K 298.28K 276.45K 116.26K 1.47M 16.46K 15.75K 15.75K 20.58M 15.75K 10.76K 14.52M
EPS (Basic)
-0.92 -2.48 -5.32 -15.95 -22.37 -24.54 -33.52 -124.5 -295.49 -473.09 -633.79 -746.04 -809.62 -787.58 -3.24K -3.31K -3.35K -3.56K
EPS (Diluted)
-0.92 -2.48 -5.32 -15.95 -22.37 -24.54 -33.52 -122.15 -293.14 -470.74 -631.44 -735.38 -798.96 -776.92 -3.23K -3.31K -3.35K -3.56K
EBITDA
-31.48M -24.19M -17.58M -14.53M -12.54M -10.07M -7.68M -6.98M -7.9M -9.64M -10.93M -11.59M -12.48M -11.34M -32.36M -31.98M -30.4M -30.83M
EBIT
-31.48M -24.2M -17.58M -14.53M -12.55M -10.08M -7.69M -7.01M -7.96M -9.72M -11.04M -11.71M -12.59M -11.44M -32.47M -32.09M -30.51M -30.94M
Depreciation & Amortization
-1.89K -892 1K 5.71K 8.57K 8.57K 7.57K 32.07K 59.61K 86.62K 113.33K 110.96K 108.71K 106.37K 108.98K 111.64K 114.26K 116.98K